Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5445676 | 0.86 | ALDH1A1 (0.42) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL5096432 | 0.85 | ALDH1A1 (0.47) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL3277090 | 0.85 | MAPK1 (0.39) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL14410610 | 0.85 | KDM4E (0.50) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL14503818 | 0.84 | ALDH1A1 (0.40) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL5443361 | 0.83 | MAPK1 (0.45) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL14489594 | 0.83 | MAPK1 (0.45) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL5433238 | 0.83 | ALDH1A1 (0.45) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL14491952 | 0.82 | ALDH1A1 (0.42) | MAPK1ALDH1A1TSHRKMT2APOLB | |
| SCHEMBL14108156 | 0.80 | KDM4E (0.43) | MAPK1ALDH1A1TSHRKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208038-A1 | 6-(2-Fluorophenyl)-Triazolopyrimidines, Method for Producing Them, Their use for Controlling Parasitic Fungi and Agents Containing the Same | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-06 | — | — | US | claimed |
| US-20070208038-A1 | 6-(2-Fluorophenyl)-Triazolopyrimidines, Method for Producing Them, Their use for Controlling Parasitic Fungi and Agents Containing the Same | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-06 | — | — | US | disclosed |
| EP-1732927-A2 | 6-(2-FLUOROPHENYL)-TRIAZOLOPYRIMIDINES, METHOD FOR PRODUCING THEM, THEIR USE FOR CONTROLLING PARASITIC FUNGI AND AGENTS CONTAINING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005095404-A2 | 6-(2-FLUOROPHENYL)-TRIAZOLOPYRIMIDINES, METHOD FOR PRODUCING THEM, THEIR USE FOR CONTROLLING PARASITIC FUNGI AND AGENTS CONTAINING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208038-A1 | 6-(2-Fluorophenyl)-Triazolopyrimidines, Method for Producing Them, Their use for Controlling Parasitic Fungi and Agents Containing the Same | CBR1, CBR3, DPM1 | MAPK1 1212/4885ALDH1A1 1276/4885TSHR 2092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.